Histological characteristics of metastasizing thin melanomas - A case-control study of 43 cases

被引:125
作者
Guitart, J
Lowe, L
Piepkorn, M
Prieto, VG
Rabkin, MS
Ronan, SG
Shea, CR
Tron, VA
White, W
Barnhill, RL
机构
[1] Northwestern Univ, Sch Med, Dept Dermatol, Chicago, IL 60611 USA
[2] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
[3] Univ Washington, Dept Dermatol, Seattle, WA 98195 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[5] Rabkin Dermatopathol Lab, Pittsburgh, PA USA
[6] Univ Illinois, Dept Pathol, Chicago, IL USA
[7] Duke Univ, Dept Dermatol, Durham, NC USA
[8] Univ Alberta, Dept Pathol, Edmonton, AB T6G 2E1, Canada
[9] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA
[10] Georgetown Univ, Med Ctr, Dept Dermatol, Washington, DC 20007 USA
关键词
D O I
10.1001/archderm.138.5.603
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective: To study clinical and histological features associated with metastasizing thin melanomas (MTMs) Design: Case-control study of clinic of pathological features of patients with MTMs by a panel of 10 dermatopathologists. Setting: Members of the North American Melanoma Pathology Study Group selected the cases from the melanoma databases at 8 academic institutions. Patients: Forty-three patients with MTMs (<1 mm thick) and 42 control subjects without metastasis matched for age, sex, tumor site, and Breslow thickness. Intervention: None. Main Outcome Measures: Clinical (age, sex, site of lesion, stage at diagnosis, metastasis site, disease-free survival, and outcome) and histological (Breslow thickness, Clark level, growth phase, regression, and inflammatory response) features of patients with MTMs vs controls. Results: There was an overrepresentation of axial tumors among patients with MTMs. Extensive regression was present in 18 patients (42%) with MTM vs 2 matched control subjects (5%) (95% confidence interval, 21%-53%;P=.001). Other histological variables were not significantly different. Two patients had melanomas in situ with subsequent metastasis. Conclusions: Thin melanomas with extensive regression represent a group at higher risk for the development of metastasis. Furthermore, the risk of metastasis cannot be dismissed in cases of melanoma in situ.
引用
收藏
页码:603 / 608
页数:6
相关论文
共 53 条
[1]   Prognosis of thin cutaneous head and neck melanoma (<1 mm) [J].
Andersson, AP ;
Dahlstrom, KK ;
Drzewiecki, KT .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 1996, 22 (01) :55-57
[2]   A COMPARISON OF PROGNOSTIC FACTORS AND SURGICAL RESULTS IN 1,786 PATIENTS WITH LOCALIZED (STAGE-1) MELANOMA TREATED IN ALABAMA, USA, AND NEW-SOUTH-WALES, AUSTRALIA [J].
BALCH, CM ;
SOONG, SJ ;
MILTON, GW ;
SHAW, HM ;
MCGOVERN, VJ ;
MURAD, TM ;
MCCARTHY, WH ;
MADDOX, WA .
ANNALS OF SURGERY, 1982, 196 (06) :677-684
[3]  
BARNHILL RL, 1993, AM J PATHOL, V143, P99
[4]  
Barnhill RL, 1996, CANCER-AM CANCER SOC, V78, P427
[5]  
Barnhill RL, 1998, CUTANEOUS MELANOMA, P103
[6]   STEREOLOGIC ESTIMATION OF VOLUME-WEIGHTED MEAN NUCLEAR VOLUME AS A PREDICTOR OF PROGNOSIS IN THIN MALIGNANT-MELANOMA [J].
BINDER, M ;
DOLEZAL, I ;
WOLFF, K ;
PEHAMBERGER, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 99 (02) :180-183
[7]  
BJORNHAGEN V, 1993, MED ONCOL TUMOR PHAR, V10, P87
[8]   HISTOLOGICAL REGRESSION IN PRIMARY CUTANEOUS MELANOMA - RECOGNITION, PREVALENCE AND SIGNIFICANCE [J].
BLESSING, K ;
MCLAREN, KM .
HISTOPATHOLOGY, 1992, 20 (04) :315-322
[9]   THIN MALIGNANT MELANOMAS (LESS-THAN-1.5 MM) WITH METASTASIS - A HISTOLOGICAL STUDY AND SURVIVAL ANALYSIS [J].
BLESSING, K ;
MCLAREN, KM ;
MCLEAN, A ;
DAVIDSON, P .
HISTOPATHOLOGY, 1990, 17 (05) :389-395
[10]   EXPERIENCE OF THIN CUTANEOUS MELANOMAS (LESS-THAN 0.76MM AND LESS-THAN 0.85MM THICK) IN A LARGE PLASTIC-SURGERY UNIT - A 5 TO 17 YEAR FOLLOW-UP [J].
BRIGGS, JC ;
IBRAHIM, NBN ;
HASTINGS, AG ;
GRIFFITHS, RW .
BRITISH JOURNAL OF PLASTIC SURGERY, 1984, 37 (04) :501-506